Update on primary head and neck mucosal melanoma

Fernando Lõpez, Juan P. Rodrigo, Antonio Cardesa, Asterios Triantafyllou, Kenneth O. Devaney, William M. Mendenhall, Missak Haigentz, Primož Strojan, Phillip K. Pellitteri, Carol R. Bradford, Ashok R. Shaha, Jennifer L. Hunt, Remco De Bree, Robert P. Takes, Alessandra Rinaldo, Alfio Ferlito

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Primary mucosal melanomas (PMMs) of the head and neck are uncommon malignancies that arise mainly in the nasal cavity and paranasal sinuses, followed by the oral cavity. The mainstay of treatment is radical surgical resection followed by adjuvant radiotherapy in selected patients with high-risk features. Multimodality therapy has not been well studied and is not standardized. Adjuvant radiotherapy seems to improve locoregional control but does not improve overall survival (OS). Elective neck dissection is advocated in patients with oral PMM. Systemic therapy should be considered only for patients with metastatic or unresectable locoregional disease. Despite improvements in the field of surgery, radiotherapy, and systemic therapy, patients with PMM still face a very unfavorable prognosis (5-year disease-free survival [DFS]

Original languageEnglish (US)
Pages (from-to)147-155
Number of pages9
JournalHead and Neck
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Melanoma
Neck
Head
Adjuvant Radiotherapy
Paranasal Sinuses
Neck Dissection
Nasal Cavity
Therapeutics
Disease-Free Survival
Mouth
Radiotherapy
Survival
Neoplasms

Keywords

  • chemotherapy
  • diagnosis
  • head and neck
  • mucosal melanoma
  • outcomes
  • radiotherapy
  • staging system
  • surgery

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Lõpez, F., Rodrigo, J. P., Cardesa, A., Triantafyllou, A., Devaney, K. O., Mendenhall, W. M., ... Ferlito, A. (2016). Update on primary head and neck mucosal melanoma. Head and Neck, 38(1), 147-155. https://doi.org/10.1002/hed.23872

Update on primary head and neck mucosal melanoma. / Lõpez, Fernando; Rodrigo, Juan P.; Cardesa, Antonio; Triantafyllou, Asterios; Devaney, Kenneth O.; Mendenhall, William M.; Haigentz, Missak; Strojan, Primož; Pellitteri, Phillip K.; Bradford, Carol R.; Shaha, Ashok R.; Hunt, Jennifer L.; De Bree, Remco; Takes, Robert P.; Rinaldo, Alessandra; Ferlito, Alfio.

In: Head and Neck, Vol. 38, No. 1, 01.01.2016, p. 147-155.

Research output: Contribution to journalArticle

Lõpez, F, Rodrigo, JP, Cardesa, A, Triantafyllou, A, Devaney, KO, Mendenhall, WM, Haigentz, M, Strojan, P, Pellitteri, PK, Bradford, CR, Shaha, AR, Hunt, JL, De Bree, R, Takes, RP, Rinaldo, A & Ferlito, A 2016, 'Update on primary head and neck mucosal melanoma', Head and Neck, vol. 38, no. 1, pp. 147-155. https://doi.org/10.1002/hed.23872
Lõpez F, Rodrigo JP, Cardesa A, Triantafyllou A, Devaney KO, Mendenhall WM et al. Update on primary head and neck mucosal melanoma. Head and Neck. 2016 Jan 1;38(1):147-155. https://doi.org/10.1002/hed.23872
Lõpez, Fernando ; Rodrigo, Juan P. ; Cardesa, Antonio ; Triantafyllou, Asterios ; Devaney, Kenneth O. ; Mendenhall, William M. ; Haigentz, Missak ; Strojan, Primož ; Pellitteri, Phillip K. ; Bradford, Carol R. ; Shaha, Ashok R. ; Hunt, Jennifer L. ; De Bree, Remco ; Takes, Robert P. ; Rinaldo, Alessandra ; Ferlito, Alfio. / Update on primary head and neck mucosal melanoma. In: Head and Neck. 2016 ; Vol. 38, No. 1. pp. 147-155.
@article{9e57db0b62e64aac8516e79c89b4b6bd,
title = "Update on primary head and neck mucosal melanoma",
abstract = "Primary mucosal melanomas (PMMs) of the head and neck are uncommon malignancies that arise mainly in the nasal cavity and paranasal sinuses, followed by the oral cavity. The mainstay of treatment is radical surgical resection followed by adjuvant radiotherapy in selected patients with high-risk features. Multimodality therapy has not been well studied and is not standardized. Adjuvant radiotherapy seems to improve locoregional control but does not improve overall survival (OS). Elective neck dissection is advocated in patients with oral PMM. Systemic therapy should be considered only for patients with metastatic or unresectable locoregional disease. Despite improvements in the field of surgery, radiotherapy, and systemic therapy, patients with PMM still face a very unfavorable prognosis (5-year disease-free survival [DFS]",
keywords = "chemotherapy, diagnosis, head and neck, mucosal melanoma, outcomes, radiotherapy, staging system, surgery",
author = "Fernando L{\~o}pez and Rodrigo, {Juan P.} and Antonio Cardesa and Asterios Triantafyllou and Devaney, {Kenneth O.} and Mendenhall, {William M.} and Missak Haigentz and Primož Strojan and Pellitteri, {Phillip K.} and Bradford, {Carol R.} and Shaha, {Ashok R.} and Hunt, {Jennifer L.} and {De Bree}, Remco and Takes, {Robert P.} and Alessandra Rinaldo and Alfio Ferlito",
year = "2016",
month = "1",
day = "1",
doi = "10.1002/hed.23872",
language = "English (US)",
volume = "38",
pages = "147--155",
journal = "Head and Neck",
issn = "1043-3074",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Update on primary head and neck mucosal melanoma

AU - Lõpez, Fernando

AU - Rodrigo, Juan P.

AU - Cardesa, Antonio

AU - Triantafyllou, Asterios

AU - Devaney, Kenneth O.

AU - Mendenhall, William M.

AU - Haigentz, Missak

AU - Strojan, Primož

AU - Pellitteri, Phillip K.

AU - Bradford, Carol R.

AU - Shaha, Ashok R.

AU - Hunt, Jennifer L.

AU - De Bree, Remco

AU - Takes, Robert P.

AU - Rinaldo, Alessandra

AU - Ferlito, Alfio

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Primary mucosal melanomas (PMMs) of the head and neck are uncommon malignancies that arise mainly in the nasal cavity and paranasal sinuses, followed by the oral cavity. The mainstay of treatment is radical surgical resection followed by adjuvant radiotherapy in selected patients with high-risk features. Multimodality therapy has not been well studied and is not standardized. Adjuvant radiotherapy seems to improve locoregional control but does not improve overall survival (OS). Elective neck dissection is advocated in patients with oral PMM. Systemic therapy should be considered only for patients with metastatic or unresectable locoregional disease. Despite improvements in the field of surgery, radiotherapy, and systemic therapy, patients with PMM still face a very unfavorable prognosis (5-year disease-free survival [DFS]

AB - Primary mucosal melanomas (PMMs) of the head and neck are uncommon malignancies that arise mainly in the nasal cavity and paranasal sinuses, followed by the oral cavity. The mainstay of treatment is radical surgical resection followed by adjuvant radiotherapy in selected patients with high-risk features. Multimodality therapy has not been well studied and is not standardized. Adjuvant radiotherapy seems to improve locoregional control but does not improve overall survival (OS). Elective neck dissection is advocated in patients with oral PMM. Systemic therapy should be considered only for patients with metastatic or unresectable locoregional disease. Despite improvements in the field of surgery, radiotherapy, and systemic therapy, patients with PMM still face a very unfavorable prognosis (5-year disease-free survival [DFS]

KW - chemotherapy

KW - diagnosis

KW - head and neck

KW - mucosal melanoma

KW - outcomes

KW - radiotherapy

KW - staging system

KW - surgery

UR - http://www.scopus.com/inward/record.url?scp=84955694684&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84955694684&partnerID=8YFLogxK

U2 - 10.1002/hed.23872

DO - 10.1002/hed.23872

M3 - Article

VL - 38

SP - 147

EP - 155

JO - Head and Neck

JF - Head and Neck

SN - 1043-3074

IS - 1

ER -